MQS Management’s Idexx Laboratories IDXX Stock Holding History

MQS Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-509	Closed	-$214K	–	554
2025 Q1	$214K	Buy	+509	New	+$221K	0.12%	352
2023 Q4	–	Sell	-597	Closed	-$261K	–	565
2023 Q3	$261K	Buy	597 +29	+5%	+$14.5K	0.16%	288
2023 Q2	$285K	Buy	+568	New	+$272K	0.19%	240
2022 Q3	–	Sell	-981	Closed	-$344K	–	497
2022 Q2	$344K	Buy	+981	New	+$400K	0.24%	183

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MQS Management's IDXX Position: Q2 2025 in Review

MQS Management sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 509 shares — an estimated $214K sold.

MQS Management first reported a position in IDXX in Q2 2022 and held it in 4 quarters. The position peaked at $344K in Q2 2022. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

MQS Management reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
MQS Management sold 509 Idexx Laboratories shares in Q2 2025, an estimated $214K.
MQS Management first reported a position in Idexx Laboratories in Q2 2022 and held it in 4 quarters.
MQS Management's Idexx Laboratories position peaked at $344K in Q2 2022.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on MQS Management's 13F filing for Q2 2025, filed 31 Jul 2025.